We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

231 hedge funds and large institutions have $2.61B invested in Axsome Therapeutics in 2023 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 90 increasing their positions, 54 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 16

75% more call options, than puts

Call options by funds: $106M | Put options by funds: $60.5M

67% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 54

33% more capital invested

Capital invested by funds: $1.97B → $2.61B (+$647M)

17% more funds holding

Funds holding: 197 → 231 (+34)

4.83% more ownership

Funds ownership: 73.31% → 78.14% (+4.8%)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

Holders
231
Holders Change
+34
Holders Change %
+17.26%
% of All Funds
3.63%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.13%
New
50
Increased
90
Reduced
54
Closed
16
Calls
$106M
Puts
$60.5M
Net Calls
+$45.1M
Net Calls Change
+$22.7M

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$73.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$56.4M
3
RI
RTW Investments
New York
+$37.1M
4
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$34M
5
DTC
Deep Track Capital
Connecticut
+$28.3M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$51.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$44.7M
3
Holocene Advisors
Holocene Advisors
New York
-$32.6M
4
Millennium Management
Millennium Management
New York
-$22.4M
5
WP
Woodline Partners
California
-$9.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
VEA
176
Virtus ETF Advisers
New York
$305K +$28.5K +387 +10%
AWM
177
Aries Wealth Management
Maine
$287K – – –
MCP
178
Mirador Capital Partners
California
$287K – – –
American Century Companies
179
American Century Companies
Missouri
$280K +$287K +3,893 New
JMFC
180
J.M. Forbes & Co
Massachusetts
$276K – – –
Victory Capital Management
181
Victory Capital Management
Texas
$270K -$6.34K -86 -2%
ONSWM
182
Old North State Wealth Management
North Carolina
$269K – – –
Public Employees Retirement Association of Colorado
183
Public Employees Retirement Association of Colorado
Colorado
$269K – – –
NC
184
NinePointTwo Capital
California
$258K +$265K +3,599 New
GT
185
Glenmede Trust
Pennsylvania
$257K – – –
FNT
186
First National Trust
Pennsylvania
$245K -$73.8K -1,000 -23%
BRWA
187
B. Riley Wealth Advisors
Florida
$241K +$247K +3,347 New
BCI
188
Brinker Capital Investments
Pennsylvania
$240K +$247K +3,344 New
OPS
189
Orion Portfolio Solutions
Nebraska
$240K +$247K +3,344 New
KFS
190
Kaizen Financial Strategies
California
$237K +$236K +3,200 New
SC
191
Shay Capital
New York
$230K +$236K +3,200 New
IB
192
Intrust Bank
Kansas
$219K +$225K +3,046 New
XT
193
XTX Topco
Cayman Islands
$206K +$212K +2,868 New
CAPTRUST Financial Advisors
194
CAPTRUST Financial Advisors
North Carolina
$205K +$210K +2,851 New
HighTower Advisors
195
HighTower Advisors
Illinois
$199K +$205K +2,778 New
AIP
196
Ameritas Investment Partners
Nebraska
$195K +$11.3K +153 +6%
TIM
197
Tortoise Investment Management
New York
$153K – – –
LSA
198
Leonteq Securities AG
Switzerland
$147K +$77.5K +1,050 +105%
MLICM
199
Metropolitan Life Insurance Company (MetLife)
New York
$128K – – –
Canada Life
200
Canada Life
Manitoba, Canada
$102K -$9.52K -129 -8%
6 7
8
9 10

AXSM Hedge Fund Activity: Q2 2023 in Review

231 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q2 2023, worth a combined $2.61B — up 33% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new AXSM positions and 16 closed out — a net gain of 34 holders — while 90 added to existing stakes and 54 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $73.8M. The largest seller was Point72 Asset Management, cutting an estimated $51.8M.

  • 231 institutional investors held Axsome Therapeutics (AXSM) as of Q2 2023, up from 197 in Q1 2023.
  • Funds reported $2.61B of Axsome Therapeutics stock for Q2 2023, up 33% quarter-over-quarter.
  • 50 funds opened new Axsome Therapeutics positions in Q2 2023 and 16 closed out, a net change of +34 holders.
  • The largest Axsome Therapeutics buyer in Q2 2023 was RA Capital Management, an estimated $73.8M added.
  • The largest Axsome Therapeutics seller in Q2 2023 was Point72 Asset Management, an estimated $51.8M sold.

Based on aggregated 13F filings for Q2 2023.